Detection and Significance of Antifungal Resistance in Oropharyngeal Candidiasis
口咽部念珠菌病抗真菌耐药性的检测及意义
基本信息
- 批准号:7932552
- 负责人:
- 金额:$ 6.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-22 至 2012-04-30
- 项目状态:已结题
- 来源:
- 关键词:ABCB1 geneAIDS/HIV problemAffectAntifungal AgentsAntifungal TherapyAzole resistanceAzolesBiological AssayCD4 Positive T LymphocytesCandidaCandida albicansCandida glabrataCandidiasisClinicalComplicationCulture TechniquesDental EpidemiologyDetectionDiseaseDrug EffluxEnzymesEpidemiologyExhibitsFungal Drug ResistanceGene ExpressionHIVInfectionMethodsMolecularMolecular Diagnostic TechniquesOralOral candidiasisOrganismOropharyngealPatientsPoint MutationPopulationPrevalencePublic HealthRecurrenceResearchResearch PersonnelResistanceRiskRisk FactorsSamplingSystemic infectionTechniquesTestingTimeYeastsbasecohortechinocandin resistanceeffective therapyefflux pumphigh riskimprovedin vivonovel diagnosticsoropharyngeal thrushoverexpressionpathogenprogramsrapid detectionresistance mechanism
项目摘要
Antifungal resistance remains an important clinical problem in the management of HIV-infected
patients with recurrent oropharyngeal candidiasis. Candida albicans is the most frequent pathogen
associated with symptomatic disease but other Candida species, such as C. glabrata, also cause
infection. These yeasts are important because they frequently exhibit antifungal resistance.
Antifungal resistance has been particularly noted in HIV-infected patients who receive frequent
courses or prolonged therapy. Molecular mechanisms of azole resistance include alterations in the
target enzyme and increased expression of multidrug efflux pumps. Rapid detection of resistant
yeasts could allow prompt initiation of effective therapy. In addition, because colonization with
resistant yeasts is an important risk factor in developing systemic infection in susceptible hosts, a
rapid test for resistant organisms could impact empirical antifungal therapy in those patients. Thus,
the objectives of this proposal are to develop novel diagnostic platforms to rapidly detect resistant
yeasts in vivo and to correlate that detection with symptomatic infection and recurrence of
oropharyngeal candidiasis. These objectives will be achieved through prospectively evaluating HIV-
infected patients presenting with oropharyngeal infection including patients with antifungal
resistance. The specific aims of this proposal are: i) to serially evaluate a cohort of HIV-infected
patients in order to determine the epidemiology and significance of real-time molecular detection of
resistant oral yeasts; ii) to develop molecular diagnostic methods to identify species of yeasts other
than Candida albicans, including C. glabrata and to correlate that detection with chromogenic
culture techniques; and iii) to develop molecular assays for detecting in vivo molecular
mechanisms of resistance including expression of drug efflux pumps. These studies will increase
understanding of the epidemiology of resistance mechanisms, determine the impact of in vivo
detection of resistant yeasts on recurrence, and ultimately improve management of patients with
oropharyngeal candidiasis as well as those at risk for invasive candidiasis.
Relevance to public health: Oral yeast infection (thrush) is an important complication in patients
with HIV/AIDS. This research is aimed at developing rapid molecular tests to detect yeasts which
are resistant to antifungal agents in order to allow early use of more effective therapy.
抗真菌耐药性仍然是艾滋病毒感染者管理中的一个重要临床问题
复发性口咽念珠菌病患者。白色念珠菌是最常见的病原体
与症状性疾病相关,但其他念珠菌属物种,例如光滑念珠菌,也会引起
感染。这些酵母很重要,因为它们经常表现出抗真菌耐药性。
在经常接受抗真菌药物治疗的 HIV 感染患者中,抗真菌耐药性尤其明显。
疗程或延长治疗。唑类耐药的分子机制包括
靶酶和增加多药外排泵的表达。快速检测耐药菌
酵母菌可以迅速启动有效的治疗。此外,由于殖民
耐药酵母菌是易感宿主发生全身感染的重要危险因素,
快速检测耐药微生物可能会影响这些患者的经验性抗真菌治疗。因此,
该提案的目标是开发新型诊断平台以快速检测耐药性
体内酵母菌并将该检测与症状感染和复发相关联
口咽念珠菌病。这些目标将通过前瞻性评估艾滋病毒-
出现口咽感染的感染患者,包括使用抗真菌药物的患者
反抗。该提案的具体目标是: i) 连续评估一组 HIV 感染者
患者以确定流行病学和实时分子检测的意义
耐药口腔酵母菌; ii) 开发分子诊断方法来鉴定其他酵母种类
比白色念珠菌,包括光滑念珠菌,并将该检测与显色相关联
培养技术; iii) 开发用于检测体内分子的分子测定法
耐药机制,包括药物流出泵的表达。这些研究将会增加
了解耐药机制的流行病学,确定体内的影响
检测复发时的耐药酵母菌,最终改善患者的管理
口咽念珠菌病以及有侵袭性念珠菌病风险的人群。
与公共卫生的相关性:口腔酵母菌感染(鹅口疮)是患者的重要并发症
患有艾滋病毒/艾滋病。这项研究旨在开发快速分子测试来检测酵母
对抗真菌药物具有抗药性,以便尽早使用更有效的治疗方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
THOMAS F. PATTERSON其他文献
THOMAS F. PATTERSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('THOMAS F. PATTERSON', 18)}}的其他基金
Relationship between in vitro antifungal resistance and in vivo response in coccidioidomycosis
球孢子菌病体外抗真菌耐药性与体内反应的关系
- 批准号:
10363481 - 财政年份:2022
- 资助金额:
$ 6.6万 - 项目类别:
Relationship between in vitro antifungal resistance and in vivo response in coccidioidomycosis
球孢子菌病体外抗真菌耐药性与体内反应的关系
- 批准号:
10541236 - 财政年份:2022
- 资助金额:
$ 6.6万 - 项目类别:
Detection and Significance of Antifungal Resistance in Oropharyngeal Candidiasis
口咽部念珠菌病抗真菌耐药性的检测及意义
- 批准号:
7231220 - 财政年份:2006
- 资助金额:
$ 6.6万 - 项目类别:
Detection and Significance of Antifungal Resistance in Oropharyngeal Candidiasis
口咽部念珠菌病抗真菌耐药性的检测及意义
- 批准号:
7415168 - 财政年份:2006
- 资助金额:
$ 6.6万 - 项目类别:
Detection and Significance of Antifungal Resistance in Oropharyngeal Candidiasis
口咽部念珠菌病抗真菌耐药性的检测及意义
- 批准号:
7609197 - 财政年份:2006
- 资助金额:
$ 6.6万 - 项目类别:
Detection and Significance of Antifungal Resistance in Oropharyngeal Candidiasis
口咽部念珠菌病抗真菌耐药性的检测及意义
- 批准号:
7246656 - 财政年份:2006
- 资助金额:
$ 6.6万 - 项目类别:
Detection and Significance of Antifungal Resistance in Oropharyngeal Candidiasis
口咽部念珠菌病抗真菌耐药性的检测及意义
- 批准号:
7809629 - 财政年份:2006
- 资助金额:
$ 6.6万 - 项目类别:
FLUCONAZOLE RESISTANCE IN OROPHARYNGEAL CANDIDIASIS
口咽念珠菌病对氟康唑的耐药性
- 批准号:
6080503 - 财政年份:1994
- 资助金额:
$ 6.6万 - 项目类别:
FLUCONAZOLE RESISTANCE IN OROPHARYNGEAL CANDIDIASIS
口咽念珠菌病对氟康唑的耐药性
- 批准号:
2132672 - 财政年份:1994
- 资助金额:
$ 6.6万 - 项目类别:
FLUCONAZOLE RESISTANCE IN OROPHARYNGEAL CANDIDIASIS
口咽念珠菌病对氟康唑的耐药性
- 批准号:
6516478 - 财政年份:1994
- 资助金额:
$ 6.6万 - 项目类别:
相似海外基金
INTEGRATING A TRANSDIAGNOSTIC PSYCHOLOGICAL INTERVENTION IN THE CARE FOR ADOLESCENTS AND YOUTH WITH HIV IN KENYA
将跨诊断心理干预纳入肯尼亚艾滋病毒感染青少年的护理中
- 批准号:
10675988 - 财政年份:2023
- 资助金额:
$ 6.6万 - 项目类别:
Intervening with Haitian Immigrants in the U.S. to Improve HIV Outcomes
对美国的海地移民进行干预以改善艾滋病毒感染结果
- 批准号:
10700451 - 财政年份:2023
- 资助金额:
$ 6.6万 - 项目类别:
ADELANTE: A Randomized Controlled Trial of an Intervention to Improve Engagement in Care for Latinos with HIV
ADELANTE:一项旨在提高拉丁裔艾滋病毒感染者护理参与度的干预措施的随机对照试验
- 批准号:
10757099 - 财政年份:2023
- 资助金额:
$ 6.6万 - 项目类别:
HIV risk and prevention behavior and the role of social support networks among precariously housed youth: A mixed-methods study
住房不稳定的青少年的艾滋病毒风险和预防行为以及社会支持网络的作用:混合方法研究
- 批准号:
10755078 - 财政年份:2023
- 资助金额:
$ 6.6万 - 项目类别:
Hepatotoxic mechanisms of anti-HIV- and anti-COVID-19 drugs and substance use disorders
抗 HIV 和抗 COVID-19 药物和物质使用障碍的肝毒性机制
- 批准号:
10684434 - 财政年份:2023
- 资助金额:
$ 6.6万 - 项目类别: